Aquaporin-4 in glioma and metastatic tissues harboring 5-aminolevulinic acid-induced porphyrin fluorescence

Eric Suero Molina, Christian Ewelt(University of Münster), Juliane Schroeteler(University Hospital Münster), Johannes Wölfer(University Hospital Münster), Hilko Ardon, Mark Klingenhöfer(University Hospital Münster), Walter Stummer(University of Münster), Markus Holling(University Hospital Münster), Bernhard Fischer(University Hospital Münster)
Clinical Neurology and Neurosurgery
July 31, 2013
10.1016/j.clineuro.2013.07.016
Cited by 18

Related Papers

Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial
|The Lancet Oncology|2006|3.4k
EXTENT OF RESECTION AND SURVIVAL IN GLIOBLASTOMA MULTIFORME
|Neurosurgery|2008|1k
Fluorescence-guided resection of glioblastoma multiforme utilizing 5-ALA-induced porphyrins: a prospective study in 52 consecutive patients
|Journal of neurosurgery|2000|880
Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial
|The Lancet|2019|581
What is the Surgical Benefit of Utilizing 5-Aminolevulinic Acid for Fluorescence-Guided Surgery of Malignant Gliomas?
|Neurosurgery|2015|368